Search the Newsreel

Investors in Embecta Corp. (EMBC): Protect Your Rights - Contact Levi & Korsinsky Before August 17, 2026

Levi & Korsinsky, LLP has filed a securities class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who purchased securities between November 25, 2025, and May 4, 2026. The lawsuit alleges that Embecta made false and misleading statements about its financial …

Nectar Lifesciences Extends Empty Hard Gelatin Capsule Business Sale Completion to July 31, 2026

Galaxy Surfactants Limited (GALAXYSURF.NS) stock price, news, quote and history

Cellectar Biosciences to Report Second Quarter 2026 Financial Results and Provide Corporate Update on August 13

Cellectar Biosciences, Inc. will report its second quarter 2026 financial results and provide a corporate update on August 13, 2026, at 8:30 a.m. Eastern Time. The company, which focuses on cancer drug development using its proprietary Phospholipid Drug Conjugate™ platform, has several drug candidates …

Lost Money on Embecta Corp. (EMBC)? Join Class Action Suit Seeking Recovery - Contact SueWallSt

SueWallSt has announced a class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who purchased securities between November 25, 2025, and May 4, 2026. The lawsuit alleges false and misleading statements led to a 57.8% drop in Embecta's share value after …

CLRB Q1 2026 Earnings: Narrower-Than-Expected Loss Beats Estimates by 32% - Weak Earnings Momentum

Octave Specialty Group (OSG) Expected to Post Quarterly Earnings on Thursday

Cellectar Biosciences Inc (CLRB) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Cellectar Biosciences Inc (CLRB), noting its current valuation score of 7.10, which ranks 138 out of 155 in the Pharmaceuticals industry. The P/E ratio is reported at -0.46, though other key valuation metrics like P/B and P/CF …

EMBC INVESTOR ALERT: Embecta Corp. (EMBC) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit- Hagens Berman

Hagens Berman has initiated an investigation into Embecta Corp. (EMBC) following a class action lawsuit alleging misrepresentation of the commercial stability of its insulin pen needle business. The lawsuit claims Embecta misled investors about market share loss and volume softness, which led to a …

Kaplan Fox Notifies Embecta Corp. (EMBC) Investors of a Securities Class Action Deadline on August 17, 2026

Kaplan Fox & Kilsheimer LLP has announced a securities class action lawsuit against Embecta Corp. (EMBC) for investors who purchased securities between November 25, 2025, and May 4, 2026. The lawsuit stems from Embecta's Q2 fiscal 2026 results, which were significantly below expectations, leading …

EMBC Deadline Alert: Levi & Korsinsky Reminds Embecta Corp. (EMBC) Investors of Securities Class Action Deadline on August 17, 2026

Levi & Korsinsky, LLP is reminding investors of Embecta Corp. (NASDAQ: EMBC) about a securities class action lawsuit with a lead plaintiff deadline of August 17, 2026. The lawsuit alleges that Embecta made misrepresentations regarding the stability of its U.S. pen needle revenue, which …

CLRB|Cellectar Biosciences Inc|Price:2.500|Chg%:+0.080

This article provides a comprehensive stock analysis of Cellectar Biosciences Inc (CLRB) based on TradingKey's proprietary stock score. It highlights the company's strong fundamentals, high growth potential, and fair valuation within the Pharmaceuticals industry. The analysis also covers analyst ratings, institutional ownership, and risk …

Cellectar Biosciences Inc (CLRB) Institutional Confidence

This article from TradingKey focuses on the institutional confidence in Cellectar Biosciences Inc (CLRB). It provides the stock's current market data, including its price, market cap, and details institutional shareholdings and recent changes in their positions. The institutional confidence score is reported as 3.00, …

Portnoy Law Firm Announces Class Action on Behalf of Embecta Corp. Investors

The Portnoy Law Firm has announced a class action lawsuit on behalf of Embecta Corp. (NASDAQ: EMBC) investors who purchased securities between November 25, 2025, and May 4, 2026. The lawsuit alleges that Embecta made misleading statements regarding its fiscal guidance, particularly concerning weakness …

EMBC Class Reminder: Embecta Investors are Reminded of the Upcoming August 17 Deadline in the Filed Securities Fraud Class Action to Recover Losses

A securities fraud class action lawsuit has been filed against Embecta Corp. (EMBC) and its executives following a significant stock drop of over 57% on May 5, 2026. The lawsuit alleges that Embecta misled investors about the strength of its insulin pen needle product …

EMBC DEADLINE: The Gross Law Firm Reminds Embecta Corp. Investors of Upcoming Securities Class Action Deadline

The Gross Law Firm is reminding investors of Embecta Corp. (NASDAQ: EMBC) about an upcoming securities class action deadline of August 17, 2026. The lawsuit alleges that Embecta Corp. issued misleading statements regarding its fiscal results, specifically its pen needle business, leading to a …

Buy, Sell Or Hold: Bank of Baroda, Wipro, BEL, Fractal Analytics, Gland Pharma — Ask Profit

EMBC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Embecta Corp. Investors Have Opportunity to Lead Class Action Lawsuit!

Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against Embecta Corp. (NASDAQ:EMBC) and its officers. The lawsuit alleges that Embecta made false and misleading statements regarding its business and prospects, specifically about its pen needle business, which led to a significant …

Kaplan Fox Urges Investors of Embecta Corp. (EMBC) with Significant Losses to Seek a Leadership Role Before August 17, 2026

Kaplan Fox & Kilsheimer LLP has initiated a class action lawsuit against Embecta Corp. (EMBC) on behalf of investors who purchased securities between November 25, 2025, and May 4, 2026, and suffered losses. The lawsuit stems from a significant drop in Embecta's stock price …

EMBC Stock Drop: If You Incurred Significant Losses in

Robbins LLP announced a class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who purchased securities between November 25, 2025, and May 4, 2026. The lawsuit alleges that Embecta misled investors regarding its business prospects, specifically by reaffirming revenue guidance for …

EMBC INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Embecta Corp. Investors – Holzer & Holzer, LLC Encourages Investors With Losses to Contact the Firm

A class-action lawsuit has been filed against Embecta Corp. (NASDAQ: EMBC) alleging that the company made false and misleading statements and/or failed to disclose critical information regarding segment weakness, particularly in the U.S. pen needle market, which disrupted its revenue guidance and Q2 2026 …

EMBC Shareholder Alert: Embecta Corp. Securities Class Action Lawsuit - Investors Should Contact Levi & Korsinsky

Levi & Korsinsky, LLP has filed a securities class action lawsuit against Embecta Corp. (NASDAQ: EMBC) on behalf of investors who purchased shares between November 25, 2025, and May 4, 2026. The lawsuit alleges that Embecta's management concealed deteriorating conditions in the U.S. pen …

$EMBC Lawsuit Notice: BFA Law Reminds Embecta Investors of

Bleichmar Fonti & Auld LLP (BFA Law) is reminding Embecta Corp. (NASDAQ:EMBC) investors of an August 17 lead plaintiff deadline for a securities fraud class action lawsuit. This follows a 57% stock drop after Embecta allegedly made misleading statements about the strength of its …

CT Automotive Group Plc Revenue Breakdown – LSE:CTA

Cellectar Biosciences Inc (CLRB) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Cellectar Biosciences Inc (CLRB)'s historical dividends and stock splits. It notes that the company has not distributed any dividends in the past five years. However, it lists several stock split events, including a significant 30-to-1 merger split scheduled …

RIHO Partners LLC Makes New $2.54 Million Investment in Octave Specialty Group, Inc. $OSG

Galaxy Surfactants Limited (NSE:GALAXYSURF) Stock Goes Ex-Dividend In Just Three Days

Fractal Analytics net income surges 92% in Q1 FY27 as TMT bottoms out

Cellectar Biosciences Inc (CLRB) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Cellectar Biosciences Inc (CLRB), identifying major shareholders like Hexstone Capital LLC and Bleichroeder LP, and categorizing shareholder types. It also provides a historical overview of institutional shareholding, showing the number of institutions and shares held over various …

Cellectar Biosciences Inc (CLRB) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a detailed risk assessment for Cellectar Biosciences Inc (CLRB), covering various metrics related to volatility, financial risk, and investment risk. It presents data on Beta, VaR, maximum drawdown, daily returns, Sharpe Ratio, realized volatility, and liquidity. The information aims to help …

Cellectar Biosciences Inc (CLRB) Income Statement

This article presents the quarterly and annual income statements for Cellectar Biosciences Inc (CLRB), offering a detailed look into its financial performance, including total revenue, operating expenses, and net income. It also provides answers to frequently asked questions about interpreting the income statement and …

Overseas Shipholding Group Ord Shs Class A (OSG) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Overseas Shipholding Group Ord Shs Class A (OSG), focusing on volatility, financial risk, and investment risk. It presents various financial metrics such as Beta, VaR, Maximum Drawdown, Volatility, Sharpe Ratio, and Liquidity data. The data for most …

Overseas Shipholding Group Ord Shs Class A (OSG) Financial Health: Profitability & Balance Sheet Analysis

This article provides a financial analysis of Overseas Shipholding Group Ord Shs Class A (OSG), focusing on its profitability and balance sheet. It presents key financial indicators, including revenue, EPS, net profit, and debt to assets ratio, across several quarters and for FY2025. The …

Overseas Shipholding Group Ord Shs Class A (OSG) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of the dividend and stock split history for Overseas Shipholding Group Ord Shs Class A (OSG). It states that no dividends have been distributed over the past five years. The page includes current stock performance metrics and navigation options …

Cellectar Biosciences Inc (CLRB) Cash Flow

This article provides a comprehensive overview of Cellectar Biosciences Inc.'s cash flow statements, including operating, investing, and financing activities, presented in detailed quarterly and annual data. It also includes key financial metrics for CLRB and answers frequently asked questions about different types of cash …

Invicta Holdings Limited Revenue Breakdown – JSE:IVT